Found: 43
Select item for more details and to access through your institution.
Telomere Length Dynamics in Normal Individuals and in Patients with Hematopoietic Stem Cell-Associated Disorders.
- Published in:
- Annals of the New York Academy of Sciences, 2001, v. 938, n. 1, p. 293, doi. 10.1111/j.1749-6632.2001.tb03598.x
- By:
- Publication type:
- Article
The Chronic Myeloid Leukemia Stem Cell.
- Published in:
- Clinical Lymphoma & Myeloma, 2009, v. 9, p. S376, doi. 10.3816/CLM.2009.s.037
- By:
- Publication type:
- Article
HOXA5 is targeted by cell-type-specific CpG island methylation in normal cells and during the development of acute myeloid leukaemia.
- Published in:
- Carcinogenesis, 2007, v. 28, n. 2, p. 299, doi. 10.1093/carcin/bgl133
- By:
- Publication type:
- Article
Role of autophagy in cancer prevention, development and therapy.
- Published in:
- Essays in Biochemistry, 2013, v. 55, p. 133, doi. 10.1042/BSE0550133
- By:
- Publication type:
- Article
ANALYSIS OF IMATINIB IN BONE MARROW AND PLASMA SAMPLES OF CHRONIC MYELOID LEUKAEMIA PATIENTS USING SOLID PHASE EXTRACTION LC-ESI-MS.
- Published in:
- Pakistan Journal of Pharmaceutical Sciences, 2011, v. 24, n. 3, p. 285
- By:
- Publication type:
- Article
Antibody-based detection of protein phosphorylation status to track the efficacy of novel therapies using nanogram protein quantities from stem cells and cell lines.
- Published in:
- Nature Protocols, 2015, v. 10, n. 1, p. 149, doi. 10.1038/nprot.2015.007
- By:
- Publication type:
- Article
BCR- ABL1 tyrosine kinase sustained MECOM expression in chronic myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2012, v. 157, n. 4, p. 446, doi. 10.1111/j.1365-2141.2012.09078.x
- By:
- Publication type:
- Article
Restricted access to second generation tyrosine kinase inhibitors in the UK could result in suboptimal treatment for almost half of chronic myeloid leukaemia patients: results from a West of Scotland and Lothian population study.
- Published in:
- British Journal of Haematology, 2011, v. 155, n. 1, p. 128, doi. 10.1111/j.1365-2141.2011.08653.x
- By:
- Publication type:
- Article
Combined bezafibrate and medroxyprogesterone acetate have efficacy without haematological toxicity in elderly and relapsed acute myeloid leukaemia (AML).
- Published in:
- British Journal of Haematology, 2010, v. 149, n. 1, p. 65, doi. 10.1111/j.1365-2141.2009.08055.x
- By:
- Publication type:
- Article
GATA1 mutational analysis in chronic myeloid leukaemia.
- Published in:
- 2007
- By:
- Publication type:
- Letter
Poor performance of galactomannan and mannan sandwich enzyme-linked immunosorbent assays in the diagnosis of invasive fungal infection.
- Published in:
- 2005
- By:
- Publication type:
- Letter
Mobilization of Ph chromosome-negative peripheral blood stem cells in chronic myeloid leukaemia patients with imatinib mesylate-induced complete cytogenetic remission.
- Published in:
- British Journal of Haematology, 2003, v. 123, n. 3, p. 479, doi. 10.1046/j.1365-2141.2003.04599.x
- By:
- Publication type:
- Article
BCR-ABL FISH MONITORING OF CML: A SURVEY OF CURRENT UK PRACTICE.
- Published in:
- British Journal of Haematology, 2002, v. 119, n. 1, p. 272, doi. 10.1046/j.1365-2141.2002.38802.x
- By:
- Publication type:
- Article
In vivo expansion of the endogenous B-cell compartment stimulated by radiation and serial bone marrow transplantation induces B-cell leukaemia in mice.
- Published in:
- British Journal of Haematology, 2001, v. 114, n. 1, p. 49, doi. 10.1046/j.1365-2141.2001.02903.x
- By:
- Publication type:
- Article
Recent advances in the molecular and cellular biology of chronic myeloid leukaemia: lessons to be learned from the laboratory.
- Published in:
- British Journal of Haematology, 2001, v. 113, n. 1, p. 11, doi. 10.1046/j.1365-2141.2001.02558.x
- By:
- Publication type:
- Article
Eradication of Chronic Myeloid Leukemia Stem Cells: A Novel Mathematical Model Predicts No Therapeutic Benefit of Adding G-CSF to Imatinib.
- Published in:
- PLoS Computational Biology, 2009, v. 5, n. 9, p. 1, doi. 10.1371/journal.pcbi.1000503
- By:
- Publication type:
- Article
Lineage Tracing of Pf4-Cre Marks Hematopoietic Stem Cells and Their Progeny.
- Published in:
- PLoS ONE, 2012, v. 7, n. 12, p. 1, doi. 10.1371/journal.pone.0051361
- By:
- Publication type:
- Article
Abcg2 Overexpression Represents a Novel Mechanism for Acquired Resistance to the Multi-Kinase Inhibitor Danusertib in BCR-ABL-Positive Cells In Vitro.
- Published in:
- PLoS ONE, 2011, v. 6, n. 4, p. 1, doi. 10.1371/journal.pone.0019164
- By:
- Publication type:
- Article
The Antiproliferative Activity of Kinase Inhibitors in Chronic Myeloid Leukemia Cells Is Mediated by FOXO Transcription Factors.
- Published in:
- Stem Cells, 2014, v. 32, n. 9, p. 2324, doi. 10.1002/stem.1748
- By:
- Publication type:
- Article
Concise Review: Cancer Cells Escape from Oncogene Addiction: Understanding the Mechanisms Behind Treatment Failure for More Effective Targeting.
- Published in:
- Stem Cells, 2014, v. 32, n. 6, p. 1373, doi. 10.1002/stem.1678
- By:
- Publication type:
- Article
Transcriptional Analysis of Quiescent and Proliferating CD34+ Human Hemopoietic Cells from Normal and Chronic Myeloid Leukemia Sources.
- Published in:
- Stem Cells, 2007, v. 25, n. 12, p. 3111, doi. 10.1634/stemcells.2007-0250
- By:
- Publication type:
- Article
Concise Review: Telomere Biology in Normal and Leukemic Hematopoietic Stem Cells.
- Published in:
- Stem Cells, 2007, v. 25, n. 8, p. 1853, doi. 10.1634/stemcells.2007-0057
- By:
- Publication type:
- Article
Targeted therapy in haematological malignancies.
- Published in:
- Journal of Pathology, 2010, v. 220, n. 4, p. 404, doi. 10.1002/path.2669
- By:
- Publication type:
- Article
Safety and efficacy of pulsed imatinib with or without G- CSF versus continuous imatinib in chronic phase chronic myeloid leukaemia patients at 5 years follow-up.
- Published in:
- British Journal of Haematology, 2013, v. 163, n. 5, p. 674, doi. 10.1111/bjh.12532
- By:
- Publication type:
- Article
Quantitative proteomics analysis of BMS-214662 effects on CD34 positive cells from chronic myeloid leukaemia patients.
- Published in:
- Proteomics, 2013, v. 13, n. 1, p. 153, doi. 10.1002/pmic.201200022
- By:
- Publication type:
- Article
Investigation into omacetaxine solution stability for in vitro study.
- Published in:
- Biomedical Chromatography, 2012, v. 26, n. 5, p. 545, doi. 10.1002/bmc.1686
- By:
- Publication type:
- Article
Cancer: Repositioned to kill stem cells.
- Published in:
- Nature, 2015, v. 525, n. 7569, p. 328, doi. 10.1038/nature15213
- By:
- Publication type:
- Article
Deregulated hedgehog pathway signaling is inhibited by the smoothened antagonist LDE225 (Sonidegib) in chronic phase chronic myeloid leukaemia.
- Published in:
- Scientific Reports, 2016, p. 25476, doi. 10.1038/srep25476
- By:
- Publication type:
- Article
Proceedings of the Third Global Workshop on Chronic Myeloid Leukemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2010, v. 10, n. 6, p. 443, doi. 10.3816/CLML.2010.n.077
- By:
- Publication type:
- Article
Arachidonate 15-lipoxygenase is required for chronic myeloid leukemia stem cell survival.
- Published in:
- Journal of Clinical Investigation, 2014, v. 124, n. 9, p. 3847, doi. 10.1172/JCI66129
- By:
- Publication type:
- Article
Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells.
- Published in:
- 2009
- By:
- Publication type:
- journal article
The use of isobaric tag peptide labeling (iTRAQ) and mass spectrometry to examine rare, primitive hematopoietic cells from patients with chronic myeloid leukemia.
- Published in:
- Molecular Biotechnology, 2007, v. 36, n. 2, p. 81, doi. 10.1007/s12033-007-0005-5
- By:
- Publication type:
- Article
DPPIV (CD26) as a novel stem cell marker in Ph+ chronic myeloid leukaemia.
- Published in:
- European Journal of Clinical Investigation, 2014, v. 44, n. 12, p. 1239, doi. 10.1111/eci.12368
- By:
- Publication type:
- Article
Predictive response-relevant clustering of expression data provides insights into disease processes.
- Published in:
- Nucleic Acids Research, 2010, v. 38, n. 20, p. 6831, doi. 10.1093/nar/gkq550
- By:
- Publication type:
- Article
In Search of CML Stem Cells' Deadly Weakness.
- Published in:
- Current Hematologic Malignancy Reports, 2011, v. 6, n. 2, p. 82, doi. 10.1007/s11899-011-0085-y
- By:
- Publication type:
- Article
Targeting Chronic Myeloid Leukemia Stem Cells.
- Published in:
- Current Hematologic Malignancy Reports, 2010, v. 5, n. 2, p. 81, doi. 10.1007/s11899-010-0043-0
- By:
- Publication type:
- Article
Tyrosine Kinase Inhibitor Independent Gene Expression Signature in CML Offers New Targets for LSPC Eradication Therapy.
- Published in:
- Cancers, 2022, v. 14, n. 21, p. 5253, doi. 10.3390/cancers14215253
- By:
- Publication type:
- Article
Therapeutic targets in chronic myeloid leukaemia.
- Published in:
- Hematological Oncology, 2007, v. 25, n. 2, p. 66, doi. 10.1002/hon.813
- By:
- Publication type:
- Article
A comparison of normal and leukemic stem cell biology in Chronic Myeloid Leukemia.
- Published in:
- Hematological Oncology, 2001, v. 19, n. 3, p. 89, doi. 10.1002/hon.667
- By:
- Publication type:
- Article
Do we need more drugs for chronic myeloid leukemia?
- Published in:
- Immunological Reviews, 2015, v. 263, n. 1, p. 106, doi. 10.1111/imr.12234
- By:
- Publication type:
- Article
A new monoclonal antibody detects downregulation of protein tyrosine phosphatase receptor type γ in chronic myeloid leukemia patients.
- Published in:
- Journal of Hematology & Oncology, 2017, v. 10, p. 1, doi. 10.1186/s13045-017-0494-z
- By:
- Publication type:
- Article
Granulocytecolony-stimulating factor (Filgrastim) may overcome imatinib-induced neutropenia in patients with chronic-phase myelogenous leukemiaThe authors were invited to reply and declined the invitation.
- Published in:
- Cancer (0008543X), 2005, v. 103, n. 1, p. 210
- By:
- Publication type:
- Article
Prediction of initial cytogenetic response for subsequent major and complete cytogenetic response to imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia.
- Published in:
- Cancer (0008543X), 2003, v. 98, n. 8, p. 1776, doi. 10.1002/cncr.11715
- By:
- Publication type:
- Article